Alivus Life Sciences Announces Change in Corporate Office Address
A change in corporate office address is an administrative update and is unlikely to have a significant material impact on the company's business operations, financial position, or stock valuation.
The announcement details a routine administrative change of the corporate office address, which does not inherently indicate positive or negative operational or financial performance for the company.
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has informed about a change in its Corporate Office address, effective 3 September 2025. * The new Corporate Office address is Technopolis Knowledge Park, A wing, 4th Floor, Mahakali Caves Road, Andheri East, Mumbai – 400093. * The previous Corporate Office address was 4th Floor, OIA House, 470 Cardinal Gracious Road, Andheri East, Mumbai – 400099.
What to do with a filing like this
Alivus Life Sciences Limited filed this with the NSE as a statutory disclosure, categorised under regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Alivus Life Sciences Limited. Read the original for the full detail.